4//SEC Filing
INOTEK PHARMACEUTICALS CORP 4
Accession 0000899243-15-001346
$RCKTCIK 0001281895operating
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 8:46 PM ET
Size
10.8 KB
Accession
0000899243-15-001346
Insider Transaction Report
Form 4
Devon Park Associates, L.P.
10% Owner
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2015-07-14−9,857→ 0 total(indirect: See Footnote)Exercise: $4.34Exp: 2024-08-28→ Common Stock (9,857 underlying) - Exercise/Conversion
Common Stock
2015-07-14$4.34/sh+9,857$42,799→ 3,253,566 total
Devon Park Associates, LLC
10% Owner
Transactions
- Exercise/Conversion
Common Stock
2015-07-14$4.34/sh+9,857$42,799→ 3,253,566 total - Exercise/Conversion
Stock Options (Right to Buy)
2015-07-14−9,857→ 0 total(indirect: See Footnote)Exercise: $4.34Exp: 2024-08-28→ Common Stock (9,857 underlying)
Kantesaria Devang
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2015-07-14$4.34/sh+9,857$42,799→ 3,253,566 total - Exercise/Conversion
Stock Options (Right to Buy)
2015-07-14−9,857→ 0 total(indirect: See Footnote)Exercise: $4.34Exp: 2024-08-28→ Common Stock (9,857 underlying)
Footnotes (3)
- [F1]The 9,857 shares of Common Stock were assigned by Dr. Devang Kantesaria to Devon Park Associates, L.P. immediately upon exercise of the underlying options. Dr. Kantesaria, along with Messrs. Marc Ostro and Christopher Moller (collectively, the "Founding Members"), are the founding and managing members of Devon Park Associates, LLC, which is the general partner of Devon Park Associates, L.P. Dr. Kantesaria is contractually obligated to assign the value of these securities to Devon Park Associates, L.P. Each Founding Member further disclaims beneficial ownership of these securities, except to the extent of such Founding Member's pecuniary interest therein, and this report shall not be deemed an admission that the Founding Members are the beneficial owner of such securities for Section16 or any other purposes.
- [F2]Fully vested.
- [F3]Options for the purchase of 9,857 shares of Common Stock were held directly by Dr. Kantesaria and assigned to Devon Park Associates, L.P. immediately upon exercise.
Documents
Issuer
INOTEK PHARMACEUTICALS CORP
CIK 0001281895
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001281895
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 8:46 PM ET
- Size
- 10.8 KB